Arrigo De Benedetti - Concepedia

Author

Arrigo De Benedetti

Louisiana State University Health Sciences Center Shreveport ORCID

Also Known As

A De Benedetti, A de Benedetti, A. Benedetti, A. De Benedetti, Arrigo Benedetti, Arrigo De Benedetti, Arrigo De De Benedetti, Arrigo De benedetti, Arrigo DeBenedetti, Arrigo De Benedetti

166

Publications

5.9K

Citations

H-Index

Concepts

All Affiliations

Louisiana State University Health Sciences Center Shreveport Louisiana State University in Shreveport Louisiana State University University of Kentucky University Medical Center

About

Arrigo De Benedetti is an author at Louisiana State University Health Sciences Center Shreveport specializing in medicine, cell biology, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	44	2.7K
2	Natural Sciences	14	15	998
3	Biochemistry	3	3	123
4	Health Sciences	1	1	43
5	Public Health	1	1	30

Arrigo De Benedetti

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Arrigo De Benedetti, Robert E. Rhoads Proceedings of the National Academy of Sciences Transcriptional RegulationSystems BiologyInitiation ComplexProtein ExpressionInitiation Factors	1990	283
Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: Implications for tumor angiogenesis Christopher G. Kevil, Arrigo De Benedetti, D. Keith Payne, International Journal of Cancer	1996	202
The proto‐oncogene/translation factor eIF4E: A survey of its expression in breast carcinomas Vaishali Kerekatte, Kyle Smiley, Bei Hu, International Journal of Cancer Proto‐oncogene/translation Factor Eif4eEif-4e AntiserumBreast OncologyMedicineCap Structure	1995	178
Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer Cherie‐Ann O. Nathan, Li Liu, Benjamin D. Li, Oncogene Tumor BiologyProto-oncogene Eif4eNeck CancerOncologyOncogenic Agent	1997	173
Expression of Antisense RNA against Initiation Factor eIF-4E mRNA in HeLa Cells Results in Lengthened Cell Division Times, Diminished Translation Rates, and Reduced Levels of Both eIF-4E and the p220 Component of eIF-4F Arrigo De Benedetti, Swati Joshi‐Barve, Carrie Rinker‐Schaeffer, Molecular and Cellular Biology Antisense RnaRibosomal SubunitsImmunologyDiminished Translation RatesP220 Component	1991	149
Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression Jeremy Crew, S Fuggle, Roy Bicknell, British Journal of Cancer	2000	139
Analysis of Surgical Margins With the Molecular Marker eIF4E: A Prognostic Factor in Patients With Head and Neck Cancer Cherie‐Ann O. Nathan, Scott Franklin, Fleurette Abreo, Journal of Clinical Oncology	1999	125
Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas Cherie‐Ann O. Nathan, Li Liu, Benjamin D. Li, Oncogene Breast OncologyAngiogenesisElevated ExpressionMedicineCancer Growth	1997	123
Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E K Smith, Richard Poulsom, Arrigo De Benedetti, British Journal of Cancer Tumor BiologyBreast OncologyAngiogenesisDifferential ExpressionMedicine	1998	115
Decreasing the level of translation initiation factor 4E with antisense rna causes reversal of <i>ras</i>‐mediated transformation and tumorigenesis of cloned rat embryo fibroblasts Carrie Rinker‐Schaeffer, Jeremy R. Graff, Arrigo De Benedetti, International Journal of Cancer	1993	114

Page 1